Relief Therapeutics Holding SA (SWX:RLF)
Switzerland · Delayed Price · Currency is CHF 2.500
+0.040 (1.63%)
Aug 12, 2025, 4:16 PM CET
Relief Therapeutics Holding Employees
Relief Therapeutics Holding had 31 employees as of December 31, 2024. The number of employees decreased by 18 or -36.73% compared to the previous year.
Employees
31
Change (1Y)
-18
Growth (1Y)
-36.73%
Revenue / Employee
$271,516
Profits / Employee
-$552,226
Market Cap
30.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | -18 | -36.73% |
| Dec 31, 2023 | 49 | -20 | -28.99% |
| Dec 31, 2022 | 69 | 14 | 25.45% |
| Dec 31, 2021 | 55 | 45 | 450.00% |
| Dec 31, 2020 | 10 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Alcon | 25,599 |
| Galderma Group AG | 6,545 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
Relief Therapeutics Holding News
- 1 day ago - Relief Therapeutics Advances Publication of 2025 Half-Year Report - Accesswire
- 14 days ago - Relief Therapeutics reports proposed business combination with NeuroX - Seeking Alpha
- 14 days ago - Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze - Accesswire
- 7 weeks ago - Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 - Accesswire
- 2 months ago - Relief Therapeutics Announces Results of Annual General Meeting - Accesswire
- 2 months ago - Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 - Accesswire
- 3 months ago - Relief Therapeutics Publishes 2025 Annual General Meeting Agenda - Accesswire
- 4 months ago - Relief Therapeutics Holding GAAP EPS of -CHF 1.37, revenue of CHF 9.83B - Seeking Alpha